New York State Common Retirement Fund
MLYS icon

New York State Common Retirement Fund’s Mineralys Therapeutics MLYS Stock Holding History

New York State Common Retirement Fund’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Buy
20,164
+4,800
+31% +$132K ﹤0.01% 1972
2026
Q1 		$416K Buy
15,364
+2,800
+22% +$82.1K ﹤0.01% 1967
2025
Q4 		$456K Hold
12,564
– – ﹤0.01% 2001
2025
Q3 		$476K Buy
12,564
+4,800
+62% +$104K ﹤0.01% 1972
2025
Q2 		$105K Hold
7,764
– – ﹤0.01% 2572
2025
Q1 		$123K Hold
7,764
– – ﹤0.01% 2421
2024
Q4 		$95.6K Hold
7,764
– – ﹤0.01% 2613
2024
Q3 		$94K Hold
7,764
– – ﹤0.01% 2614
2024
Q2 		$90.8K Sell
7,764
-678
-8% -$8.54K ﹤0.01% 2910
2024
Q1 		$109K Buy
8,442
+4,929
+140% +$60.9K ﹤0.01% 2701
2023
Q4 		$30.2K Sell
3,513
-32
-0.9% -$251 ﹤0.01% 3102
2023
Q3 		$33.7K Buy
3,545
+47
+1% +$613 ﹤0.01% 3111
2023
Q2 		$59.6K Buy
3,498
+98
+3% +$1.47K ﹤0.01% 3094
2023
Q1 		$53.2K Buy
+3,400
New +$57.2K ﹤0.01% 2977

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund's MLYS Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Mineralys Therapeutics (MLYS) stake by 31% in Q2 2026, buying an estimated $132K and bringing the position to 20,164 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

New York State Common Retirement Fund first reported a position in MLYS in Q1 2023 and has held it in 14 quarters since. 41 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • New York State Common Retirement Fund held 20,164 shares of Mineralys Therapeutics worth $544K as of Q2 2026.
  • New York State Common Retirement Fund bought 4,800 Mineralys Therapeutics shares in Q2 2026, an estimated $132K.
  • Mineralys Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1972 holding.
  • New York State Common Retirement Fund first reported a position in Mineralys Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 41 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.